Plain-English translation of NCT07426120 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 3 โ Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a botanical total coumarin cream (TC Cream) โ a plant-based topical treatment โ to see if it can safely and effectively reduce psoriasis patches on the skin. About 300 people will be randomly assigned to either use the active medication or a look-alike cream with no active ingredient, applied twice daily for 8 weeks. Researchers will measure skin improvement and track any side effects to understand whether this treatment works and is safe.
Many people with psoriasis need new treatment options that are easy to use and have fewer side effects than existing therapies. This study aims to test whether this plant-based medication could become a safe and effective topical choice for managing psoriasis.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will apply your assigned cream (either the active treatment or a placebo) to affected skin areas twice daily โ once in the morning and once in the evening โ for 8 weeks. You'll visit the clinic every 2 weeks for checkups where doctors will examine your skin, measure how much your psoriasis has improved, and ask about any symptoms or side effects you may be experiencing. The study takes about 2 months from start to finish, with regular monitoring to ensure the treatment is working and safe.
AI-generated summary from trial data ยท Jun 2, 2026 ยท Not medical advice
United States